[Asia Economy Reporter Park Hyungsoo] Microtech has added mask development, manufacturing, and sales to its business objectives. The company plans to change its name at the regular shareholders' meeting in September, considering additional contract orders for its existing business.


On the 15th, Microtech held an extraordinary shareholders' meeting and approved an agenda to add mask development and research, mask manufacturing and sales, service industry, and hygiene product manufacturing and sales to its business objectives.


For inside directors, Microtech appointed Lee Sungjin, manager of Ace Factory, Choi Hyuncheol, director of Ace Factory, and Jung Taehun, head of sales and marketing at N2Cell. For outside directors, the agenda to appoint Choi Hyojik, assistant professor of Chemical and Materials Engineering at the University of Alberta, Canada, and Kim Jungyoon, CEO of Top Team International, was also approved.


Outside director Professor Choi Hyojik gained attention in February for developing a mask that pierces and kills viruses. Since 2015, Professor Choi has been researching anti-virus and bacteria methods using salt coating. In 2017, he published research results in international journals such as Nature sister journals and Cell.


The agenda for the company name change is scheduled for September. This decision was made considering that it might cause confusion to contract partners in ongoing contracts targeted for July and August.


Based on the results of the extraordinary shareholders' meeting, Microtech plans to actively develop nano masks and enter the global quarantine market.


A Microtech official stated, "We will collaborate with our strategic partner N2Cell to establish a mask manufacturing plant and develop various nano masks suitable for children to adults, seeking global expansion."



He added, "We are preparing to expand large-scale mass production facilities in cooperation with N2Cell, which is receiving overwhelming mask supply requests from North America, Europe, and China," emphasizing, "We will promote the excellence of K-quarantine and establish ourselves as an essential primary healthcare item worldwide."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing